Loading…

Morphological Plaque Characteristics and Clinical Outcomes in Patients With Acute Coronary Syndrome and a Cancer History

Background Although patients with a cancer history have a 2 to 3 times higher risk for acute coronary syndrome (ACS), the morphological characteristics of ACS culprit plaque in those patients and their relations with clinical outcomes remain unknown. Methods and Results This retrospective, multicent...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Heart Association 2021-08, Vol.10 (15), p.e020243-e020243
Main Authors: Tanimura, Kosuke, Otake, Hiromasa, Kawamori, Hiroyuki, Toba, Takayoshi, Nagasawa, Akira, Nakano, Shinsuke, Takahashi, Yu, Fukuyama, Yusuke, Kozuki, Amane, Shite, Junya, Iwasaki, Masamichi, Kuroda, Koji, Takaya, Tomofumi, Hirata, Ken‐ichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Although patients with a cancer history have a 2 to 3 times higher risk for acute coronary syndrome (ACS), the morphological characteristics of ACS culprit plaque in those patients and their relations with clinical outcomes remain unknown. Methods and Results This retrospective, multicenter, observational cohort study included consecutive patients with ACS who underwent optical coherence tomography‐guided emergent percutaneous coronary intervention. Patients were categorized into those without a cancer history, those with a cancer history, and those currently receiving cancer treatment. ACS culprit lesions were classified as plaque rupture, plaque erosion, or calcified nodule using optical coherence tomography. Plaque erosion frequency was significantly higher in culprit lesions of patients with current cancer and patients with cancer history than in those of patients without cancer history (56.3% versus 61.7% versus 36.5%). Calcified nodule incidence was significantly higher in patients without cancer history than in patients with current cancer and patients without cancer history (patients with current cancer: 12.4% versus patients without cancer history: 25.5% versus patients without cancer history: 12.6%, P
ISSN:2047-9980
2047-9980
DOI:10.1161/JAHA.120.020243